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Expansion of the neural progenitor pool in the developing cerebral cortex is crucial for con-
trolling brain size, since proliferation defects have been associated with the pathogenesis
of microcephaly in humans. Cell cycle regulators play important roles in proliferation of
neural progenitors. Here, we show that the cyclin-dependent kinase inhibitor p21 (also
called Cdkn1a and Cip1) negatively regulates proliferation of radial glial cells (RGCs) and
intermediate progenitors (IPs) in the embryonic mouse cortex. MicroRNA-17 (miR-17) dis-
plays reciprocal expressions with p21 in the developing cortex. Opposite to p21, miR-17
promotes expansion of RGCs and IPs, as demonstrated by overexpressing miR-17 precur-
sors and miR-17 sponges that can knock down the endogenous miR-17. Moreover, p21 is a
putative target normally silenced by miR-17. Co-expression of miR-17 with p21 is sufficient
to rescue the negative regulation of p21 on progenitor proliferation. Our results indicate a
mechanism of controlling the neural progenitor pool, which is to suppress p21 by miR-17
in the developing cortex.
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INTRODUCTION
Proper proliferation and differentiation of neural stem cells
(NSCs) and neural progenitors (NPs) are crucial for the devel-
opment and function of the mammalian cerebral cortex. Radial
glial cells (RGCs) mainly reside in the cortical ventricular zone
(VZ), represent early NPs and normally divide symmetrically to
generate two RGCs, and asymmetrically to generate one RGC and
one intermediate progenitor (IP) or one differentiated neuron (1–
7). IPs mostly reside in the subventricular zone (SVZ) and divide
symmetrically to generate two differentiated neurons (2, 8–10).
The rate and timing of NP proliferation and differentiation are
tightly regulated by various cell cycle regulators (11, 12). p21 (also
known as Cdkn1a and Cip1) is a cyclin-dependent kinase (CDK)
inhibitor that has been shown to mediate the p53-induced G1
checkpoint in cell cycle regulation (13–15). Lack of p21 promotes
self-renewal of embryonic and adult NSCs via suppressing the cell
cycle exit (16–19). Because proper regulation of NP proliferation
is important for controlling brain size, p21 may play a role in
determining cortical growth (20). However, how p21 expression
levels are precisely controlled in cortical NSCs and NPs remains
unclear.
The endogenous small non-coding RNAs, microRNAs (miR-
NAs), have been shown to play crucial roles in many aspects of cell
cycle regulation in the developing nervous system (21–24). miR-
NAs normally bind to target genes and negatively regulate their
expression through imperfect complementary sequence in the 3′-
untranslated region (3′UTR) of messenger RNAs (mRNAs) (25,
26). Studies have shown that miRNAs have either reciprocal or
overlapping expression patterns with target genes in specific cells
and tissues and silence their expression at a posttranscriptional
level (27, 28). An important miRNA family is the miR-17–92 clus-
ter, which produces miR-17, 18, 19, and 92, each with conserved
seed sequences, and regulates proliferation and survival of various
cells (29–33). Our own work and others have shown that miR-17–
92 promotes proliferation of cortical NSCs and NPs (34, 35). Since
there are six miRNAs produced from the miR-17–92 cluster, and
each miRNA usually has multiple targets, the molecular mecha-
nisms of miR-17–92 function in cortical development remain an
exciting research topic.
In this study, we show that while p21 negatively regulates NP
proliferation by reducing the numbers of both RGCs and IPs in the
developing mouse cortex, miRNA miR-17 has an opposite effect
on NP development. miR-17 promotes proliferation of RGCs and
IPs through suppressing p21 expression. Our studies have identi-
fied a mechanism that controls p21 expression levels in NPs in vivo
by miR-17 during cortical development.
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MATERIALS AND METHODS
ANIMALS
CD-1 mice were used for in utero electroporation. For staging of
embryos, midday of the day of vaginal-plug formation was consid-
ered as E0.5; the first 24 h after birth were defined as P0. Animals
were maintained at the facility of Weill Cornell Medical College.
Animal use was overseen by the Animal Facility and approved by
the IACUC at the Weill Cornell Medical College.
TISSUE PREPARATION AND IMMUNOHISTOCHEMISTRY
Mouse brains were fixed in 4% paraformaldehyde (PFA) in
phosphate-buffered saline (PBS) for 1 h at room temperature
(RT), incubated in 30% sucrose in PBS overnight at 4°C, embed-
ded in OCT, and stored at −80°C until use. Brains were sec-
tioned (14µm) using a cryostat. For antigen recovery, sections
were incubated in heated (95–100°C) antigen recovery solution
(1 mM EDTA, 5 mM Tris, pH 8.0) for 20 min, and cooled down
for 20–30 min. Before applying antibodies, sections were blocked
in 10% normal goat serum (NGS) in PBS with 0.1% Tween-20
(PBT) for 1 h. Sections were incubated with primary antibodies at
4°C overnight and visualized using goat anti-rabbit IgG-Alexa-
Fluor-488, goat anti-chicken IgG-Alexa-Fluor-488, and/or goat
anti-mouse or anti-rabbit IgG-Alexa-Fluor-546 (1:300, Molecu-
lar Probes) for 1.5 h at RT. Images were captured using a Leica
digital camera under a fluorescent microscope (Leica DMI6000B)
or a Zeiss LSM510 confocal microscope.
Primary antibodies against the following antigens were used:
green fluorescent protein (GFP) (1:1000, Abcam), bromod-
eoxyuridine (BrdU) (1:50, DSHB), Pax6 (1:500, Covance), and
Tbr2 (1:500, Abcam). Cell counting in the mouse cortical tissue
was performed on a representative column with the width of 200
pixels in the cortical wall. All sections analyzed were selected from
a similar medial point on the anterior–posterior cortical axis.
QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTION PCR
Total RNA was isolated from the dorsal cortex of E15.5 mice
using RNeasy® Mini kit (Qiagen) according to manufacturer’s
instructions, and all samples were treated with DNase to remove
genomic DNA. Reverse transcription was performed using Ran-
dom Hexamer primer (Roche). The quantitative real-time reverse
transcription PCR (qRT-PCR) was performed using Power SYBR®
Green PCR Master Mix (Life Science) on an Mx4000™ Mul-
tiplex Quantitative PCR System (Stratagene) according to man-
ufacturer’s instructions. The RT primers to detect primary
transcripts for miR-17 are: F-5′-gaacctcaccttgggactga-3′; R-5′-
tgctacaagtgccctcactg-3′. The RT primers to detect p21 are: F-5′-
cggtggaactttgacttcgt-3′; R-5′-caatctgcgcttggagtgat-3′.
IN UTERO ELECTROPORATION
In utero electroporation was performed as described (34). Briefly,
electroporation was conducted at E13.5 and the brain tissues were
harvested 24 h later. Plasmid DNA was prepared using the End-
oFree Plasmid Maxi Kit (QIAGEN) according to manufacturer’s
instructions, and diluted to 2µg/µl. For co-expression of p21
and miR-17, the concentrations of p21 and miR-17 are 0.5 and
1.5µg/µl, respectively, maintaining a total plasmid concentration
of 2µg/µl. DNA solution was injected into the lateral ventricle of
the cerebral cortex, and electroporated with five 50-ms pulses at
35 V using an ECM830 electro square porator (BTX).
LUCIFERASE ASSAYS
Neuro2a cells were transfected using Lipofectamine 2000 (Invit-
rogen) using the manufacturer’s protocol. Plasmids were quan-
tified by UV spectrophotometry and used for transfection in
a 2:1 ratio (miRNA: target luciferase constructs); 8:2:1 ratio
(sponge:miRNA:target luciferase constructs). pGL4.13 Firefly
luciferase (Promega) was used for 3′UTRs of targets. pGL4.73
Renilla luciferase (Promega) was used as a transfection control.
Luciferase was measured using the Dual-Luciferase Reporter Assay
kit (Promega) using the manufacturer’s protocol and read on aVic-
tor3 1420 multilabel counter (Perkin Elmer). All conditions were
run in triplicate, and all experiments were repeated at least once
with similar results. Raw data for each condition were normalized
for transfection efficiency as the ratio of Firefly luciferase to Renilla
luciferase, normalized to the corresponding empty pGL4.13 col-
umn to correct for DNA quantification errors, and finally for each
luciferase tested, the empty vector control experiment was set to 1
for display.
CLONING OF CONSTRUCTS
Cloning of constructs was done by standard PCR based meth-
ods. cDNA from E15.5 C57Bl/6J mice was used. miR-17 iso-
form precursors were cloned into the pGEM-T vector (Promega)
using the following primers: F-5′-cactcgaggtgacagaatttagagctttgg-
3′; R-5′-actggacgcagccagtgccg-3′. Mutations of miR-17 in the
seed sequence were generated using the QuikChange II Site-
Directed Mutagenesis Kit (Agilent Technologies) using the fol-
lowing primers:
F-5′-gtcagaataatgtcgttgtgcttacagtgcaggtagtgatgtgtgcatctactgcagtg
agggcacaagtagcattatgctgac-3′;
R-5′-gtcagcataatgctacttgtgccctcactgcagtagatgcacacatcactacctgcact
gtaagcacaacgacattattctgac-3′.
Full length cDNA for p21 was cloned using the fol-
lowing primers: F-5′-gactcgaggcaccatgtccaatcctggtgatg-3′; R-5′-
cacttcagggttttctcttgcagaag-3′. To knock down p21, the following
oligos were used to make short hairpin RNA (shRNA):
m-P21-top1: 5′-agtgtgccgttgtctcttcttcaagagagaagagacaacggcacact
tttttt-3′
m-P21-bottom1: 5′-aattaaaaaaagtgtgccgttgtctcttctctcttgaagaagag
acaacggcacactggcc-3′
m-P21-top2: 5′-cggtggaactttgacttcgttcaagagacgaagtcaaagttccaccg
tttttt-3′
m-P21-bottom2: 5′-aattaaaaaacggtggaactttgacttcgtctcttgaacgaagt
caaagttccaccgggcc-3′
m-P21-top3: 5′-ctttgacttcgtcacggagttcaagagactccgtgacgaagtcaaag
tttttt-3′
m-P21-bottom3: 5′-aattaaaaaactttgacttcgtcacggagtctcttgaactccgt
gacgaagtcaaagggcc-3′
The 3′UTR fragment for p21 were subcloned into
pGL4.13 vector (Promega) using the following primers: F-
5′-ataagaatgcggccgccatcttcggccttagccctc-3′; R-5′-gaggactcgggacaat
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gcag-3′. For luciferase assays, the miR-17 precursor and its
mutation were subcloned into the pCDNA3.1 vector.
For cloning miR-17 sponge, the following primers were used:
5′-gtaggaatcttcgaaagctatacaccgctcgagactagtctacctgcactgccgcacttt
ggttatcctacctgcactgccgcactttggttatcctacctgcactgccgcactttgtctaga
gcttacgttagaatcgcattcg-3′
For cloning miR-17 sponge mutations, the following primers
were used: 5′-gtaggaatcttcgaaagctatacaccgctcgagactagtctacctgcactg
ccgccgcttggttatcctacctgcactgccgccgcttggttatcctacctgcactgccgccgct
tgtctagagcttacgttagaatcgcattcg-3′
They were then subcloned into the pCAGIG vector for electro-
poration, and pCDNA3.1 vector for luciferase assays.
WESTERN BLOT ANALYSIS
Expression levels of p21 were analyzed by the western blot analysis.
Protein extracts were harvested by lysing N2a cells transfected with
combinations of p21 and shRNA for p21 with RIPA lysis buffer
(150 mM NaCl, 1 mM Na4P2O7, 1 mM NaF, 1 mM EDTA, 1 mM
PMSF, 2 mM Na3VO4, 1% NP-40, 50 mM Tris, pH 7.5) with com-
plete™ EDTA-free protease inhibitor mixture (Roche Diagnostics,
Indianapolis, IN, USA). The protein samples were boiled in SDS
sample buffer for 10 min before loading onto 10% Tris-Glycine gels
as 10µg for each lane and transferred onto PVDF membrane (Pall
Corporation, Pensacola, FL, USA). For immunoblotting, mem-
branes were blocked with 5% (w/v) non-fat milk powder in 0.05%
TBST [50 mM Tris-Cl, pH 7.5, 150 mM NaCl, with 0.05% (v/v)
Tween-20] and incubated at 4°C overnight with the following pri-
mary antibodies, which were diluted in 0.05% TBST with 5%
non-fat milk: p21 and actin. After washing with TBST, mem-
branes were incubated with specific HRP-conjugated secondary
antibodies for 1 h at RT followed with extended washes with TBST.
Immunoblot reactions were visualized using chemiluminescent
substrate (Pierce, Rockford, IL, USA) on Kodak BioMax light films
(Kodak, Rochester, NY, USA).
RESULTS
p21 NEGATIVELY REGULATES EXPANSION OF RGCs AND IPs IN
EMBRYONIC CORTICES
Previous studies have shown that p21 usually inhibits self-renewal
of NSCs (16–19). To test whether p21 specifically affects prolif-
eration of RGCs and IPs, we examined p21 effects by altering its
expression levels in mouse embryonic cortices utilizing in utero
electroporation (Figure 1A). To overexpress p21, mouse p21 full
length cDNA was cloned into a pCAGIG vector with a GFP
reporter gene. The electroporation was conducted at embryonic
day 13.5 (E13.5) and brain tissues were harvested 24 h later, with a
single pulse of BrdU 1 h before tissue collection (Figure 1A). The
electroporated cells in E14.5 cortices were detected by the GFP
activity in green (Figure 1B).
A significantly decreased percentage of BrdU+/GFP+ cells
versus total GFP+ cells in cortices was detected, suggesting a
reduced proliferating NP population when p21 is overexpressed
(Figures 1C,D). We then examined the impact of overexpressed
p21 on producing RGCs and IPs, by labeling with antibodies
against Pax6 – a marker for RGCs, and Tbr2 – a marker for
IPs, respectively. There was a significant decrease in percentages
of Pax6+/GFP+ and Tbr2+/GFP+ cells versus total GFP+ cells,
indicating a suppression of maintenance of RGCs and IPs by p21
overexpression (Figures 1E–H).
We next used a short hairpin RNA to knock down endoge-
nous p21 expression (Figure 2A). When the endogenous p21
expression was knocked down using p21 short hairpin RNA-3
(p21–shRNA-3), we found a significant increase in the percent-
age of BrdU+/GFP+ cells (Figures 2B,C). The percentage of
Pax6+/GFP+ cells was also greatly increased, suggesting expanded
RGC populations (Figures 2D,E). Interestingly, the percentage of
Tbr2+/GFP+ cells was decreased, suggesting that knockdown of
p21 affects transition of RGCs to IPs (Figures 2F,G). Our results
indicate that p21 negatively regulates proliferation of cortical NPs,
and affects expansion and transition of RGCs and IPs.
p21 IS A PUTATIVE TARGET OF miR-17
To maintain a proper population of NPs in early developing cor-
tices, it appears that p21 expression should be precisely modulated,
especially repressed. We postulated that miRNA-mediated gene
silencing regulation might be one of the mechanisms controlling
p21 expression. Based on miRNA prediction algorithm Targetscan
(http://www.targetscan.org), we searched the 3′UTR of p21 and
found that it contains one binding site for miR-17 (Figure 3A).
To prove the targeting effect of miR-17 on p21, we designed a
luciferase assay in which the 3′UTR sequence of p21 was cloned
into a luciferase vector and co-transfected with miR-17. While
relative luciferase activities in constructs containing the 3′UTR
of p21 were not affected by a control miRNA miR-9, they were
significantly reduced by miR-17 (Figure 3B). However, when a
mutated miR-17 containing mutations in the seed sequence, which
is responsible for binding to p21 3′UTR, was used, the targeting
effect of miR-17 was abolished (Figure 3B). These results indicate
that p21 is a specific target of miR-17.
We next examined whether the expression level of p21 is corre-
lated with miR-17 expression in developing cortices by performing
qRT-PCR. Total RNAs were extracted from E13.5, E14.5, E15.5,
E17.5, and postnatal day 0 (P0) cortices. While the expression
level of miR-17 was decreased from E12.5 to P0, p21 expres-
sion was continuously increased, suggesting a reciprocal expres-
sion between miR-17 and its target p21 during cortical develop-
ment (Figures 3C–E). These results suggest that miR-17 silencing
regulation of p21 likely controls NP population in embryonic
cortices.
miR-17 POSITIVELY REGULATES PROLIFERATION OF CORTICAL NEURAL
PROGENITORS
We next investigated the effect of miR-17 on NP development
in vivo. In E14.5 cortices, electroporated with the miR-17 pre-
cursor to overexpress miR-17 at E13.5, there was a significant
increase in the percentage of BrdU+/GFP+ cells, which suggests
an up-regulation of proliferation of cortical NPs (Figures 4A,B).
Moreover, the percentages of Pax6+/GFP+ and Tbr2+/GFP+ cells
were also increased, indicating an expansion of RGCs and IPs by
miR-17 overexpression (Figures 4C–F). On the other hand, muta-
tions of miR-17 in the seed sequence (miR-17 mut) had no effect
on proliferation of RGCs and IPs, indicating a specific effect of
miR-17 on NP development (Figures 4C–F). Our results suggest
that miR-17 promotes proliferation of cortical NPs.
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FIGURE 1 | p21 negatively regulates proliferation of cortical neural
progenitors. (A)The electroporation was conducted at E13.5 and the brain
tissues were harvested 24 h later. A single intraperitoneal injection of BrdU
was performed 1 h before tissue collection. (B)The cells located in the
ventricular zone (VZ) of mouse cortices were electroporated with exogenous
plasmids carrying green fluorescent protein (GFP) at E13.5. The GFP cells can
be visualized under microscope at E14.5. (C,D) Overexpressing p21 in E13.5
mouse cortices (n=4), analyzed at E14.5, decreased the number of
proliferating cells co-labeled with GFP and BrdU compared with the empty
vector pCAGIG (n=4). (E,F) Overexpressing p21 (n=6) decreased the
number of radial glial cells (RGCs) co-labeled with GFP and Pax6 compared
with the empty vector pCAGIG (n=4). (G,H) Overexpressing p21 (n=5)
decreased the number of intermediate progenitors (IPs) co-labeled with GFP
and Tbr2 compared with the empty vector pCAGIG (n=4). Data are
presented as mean±SEM; n≥3 in all constructs; p values in relation to the
control (*p<0.05, **p<0.01, ***p<0.001).
BLOCKING miR-17 USING ITS SPONGE CAUSES REDUCED
PROLIFERATION OF CORTICAL NEURAL PROGENITORS
To further test miR-17 functions in expansion of cortical NPs, we
applied a loss-of-function approach by expressing miR-17 sponges
(36). A miRNA sponge is a RNA transcript that contains multi-
ple binding sequences complementary to a mature miRNA. It can
bind to endogenous miRNAs and block their silencing activity
(37, 38). We designed the miR-17 sponge (miR-17 sp), which con-
sists of three narrowly spaced, bulged binding sites for miR-17
(Figure 5A). To verify the blocking effect of miR-17 sponge on the
miR-17 silencing activity, we performed the luciferase assay. The
miR-17 sponge was cloned in the 3′UTR of a coding gene iCre,
and co-transfected with miR-17 and the construct containing the
luciferase gene followed by the 3′UTR sequence of p21. The reduc-
tion of the relative luciferase activity, which is normally caused
by the silencing effect of miR-17, was significantly rescued by the
miR-17 sponge (Figure 5B). However, a mutated miR-17 sponge
at the seed sequence showed no such rescue effect. These data indi-
cate that the miR-17 sponge is able to block the silencing function
of miR-17 to its target gene p21.
To further test the effect of miR-17 sponge on expansion
of cortical NPs in vivo, the miR-17 sponge was electroporated
into the cortices of E13.5 mice, and analyzed at E14.5. The per-
centages of BrdU+/GFP+, Pax6+/GFP+, and Tbr2+/GFP+ cells
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FIGURE 2 | Knockdown of p21 increases proliferation of cortical neural
progenitors. (A)Western blotting analyses of p21 short hairpin RNA to knock
down endogenous p21 expression levels using RNA interference (RNAi).
(B,C) Blocking the p21 expression (n= 4) using a p21 short hairpin RNA-3
(p21–shRNA-3) in E13.5 mouse cortices, analyzed at E14.5, increased the
number of proliferating cells co-labeled with GFP and BrdU compared with
the empty vector pSilencer (n=3). (D,E) Blocking the p21 expression (n=5)
using the p21–shRNA increased the number of RGCs co-labeled with GFP
and Pax6. (F,G) Blocking the p21 expression (n= 6) using the p21–shRNA
decreased the number of IPs co-labeled with GFP and Tbr2. Data are
presented as mean±SEM; n≥3 in all constructs; p values in relation to the
control (*p<0.05, **p<0.01).
versus total GFP+ cells were all decreased significantly when
the miR-17 sponge was expressed (Figures 5C–H). The mutated
miR-17 sponge (miR-17 sp-mut), however, did not show effects
to the RGCs and IPs, compared to the empty vector and miR-
17 sponge (Figures 5C–H). These results indicate that the miR-17
sponge, which can block the endogenous miR-17 silencing activity,
suppresses proliferation of cortical NPs.
miR-17 RESCUES THE NEGATIVE EFFECT OF p21 ON PROLIFERATION OF
NEURAL PROGENITORS
To directly test the silencing activity of miR-17 on p21 in vivo, we
speculated that co-expression of miR-17 with p21 should be able to
rescue the negative effect of p21 on proliferation of NPs. The p21
full length cDNA with the 3′UTR was cloned into the pCAGIG
vector, co-electroporated with miR-17 into E13.5 cortices, and
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FIGURE 3 | p21 is a putative target of miR-17. (A) A predicted targeting
site of miR-17 on the 3′UTR of p21. (B) Luciferase activities of the p21
3′UTR construct were greatly reduced by miR-17, but not by miR-17
mutation or a control microRNA miR-9. miR-17 had no effect on pGL4.13
construct in which the p21 3′UTR had been removed. (C)The expression
level of p21 in the mouse cortex continuously increased from E12.5 to P0.
(D)The expression level of miR-17 in the mouse cortex continuously
decreased from E12.5 to P0. (E) A combined view of the expression levels
of p21 and miR-17 at different developing stages. Data are presented as
mean±SEM; n= 3; ***p<0.001.
FIGURE 4 | miR-17 positively regulates proliferation of cortical neural
progenitors. (A,B) Expression of miR-17 in E13.5 mouse cortices (n=3),
analyzed at E14.5, increased the number of proliferating cells co-labeled with
GFP and BrdU. A mutated miR-17 (miR-17 mut) (n=3) had no effect on cell
proliferation. (C,D) Expression of miR-17 in E13.5 mouse cortices (n=4)
increased the number of RGCs co-labeled with GFP and Pax6. A mutated
miR-17 (n=3) had no effect on the number of RGCs. (E,F) Expression of
miR-17 in E13.5 mouse cortices (n=4) increased the number of IPs
co-labeled with GFP and Tbr2. A mutated miR-17 (n= 3) had no effect on the
number of IPs. Data are presented as mean±SEM; n≥3 in all constructs; p
values in relation to the control (*p<0.05, **p<0.01, ***p<0.001), n.s., not
significant.
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FIGURE 5 | Blocking miR-17 using its sponge causes reduced
proliferation of cortical neural progenitors. (A)The design of the miR-17
sponge. (B)The reduction of the relative luciferase activity caused by miR-17
was significantly rescued by the miR-17 sponge, but not by miR-17 sponge
mutation. The luciferase activity values were normalized by the average
luciferase activity value of the empty vector pcDNA to get a ratio. In all
experiments, the pcDNAs luciferase activity value was normalized as 1, and
the values of other constructs were the ratios of their luciferase activity
values to their pcDNA controls. (C,D) Expression of miR-17 sponge (miR-17
sp) in E13.5 mouse cortices (n=4), analyzed at E14.5, decreased the number
of proliferating cells co-labeled with GFP and BrdU. A mutated miR-17 sponge
(miR-17 sp-mut) (n=3) failed to do so. (E,F) Expression of miR-17 sponge in
E13.5 mouse cortices (n=6) decreased the number of RGCs co-labeled with
GFP and Pax6. A mutated miR-17 sponge (n= 3) failed to do so.
(G,H) Expression of miR-17 sponge in E13.5 mouse cortices (n=4) decreased
the number of IPs co-labeled with GFP and Tbr2. A mutated miR-17 sponge
(n=4) failed to do so. Data are presented as mean±SEM; n≥3 in all
constructs; p values in relation to the control (*p<0.05, ***p<0.001).
analyzed at E14.5. Compared to p21 alone, co-expression of miR-
17 and p21 significantly rescued NP proliferation, as demonstrated
by increased percentages of BrdU+/GFP+, Pax6+/GFP+, and
Tbr2+/GFP+ cells, which were compatible to those electroporated
with the control vector (Figures 6A–F). However, co-expression
of p21 and the mutated miR-17 failed to rescue NP prolifera-
tion (Figures 6A–F). These results are consistent with those of the
luciferase assay, and prove that miR-17 blocks the negative effect
of p21 on proliferation of NPs in vivo, especially RGCs and IPs in
developing cortices.
DISCUSSIONS
Accumulating evidence has shown that protein-coding genes and
miRNAs play indispensable roles in mammalian neural develop-
ment. In our studies, we have identified p21 as a negative regulator
of RGC and IP expansion in the mouse embryonic cortex. Utilizing
in utero electroporation and miRNA sponge, we have found that
miR-17 specifically blocks p21 expression, thereby promoting the
expansion of the cortical neural progenitor pool. Our studies have
revealed a mechanism of suppressing endogenous p21 expression
by miR-17 in NPs.
Many studies have shown that p21 functions as a negative cell
cycle regulator and induces cell cycle exit (13–15). In the nervous
system, p21 has been shown to suppress self-renewal and pro-
liferation of NSCs and NPs (16–19). An important question is
how the p21 gene expression level is properly regulated in vivo.
In the developing cortex, to produce sufficient numbers of NPs
to form a functional brain, p21 expression has to be suppressed.
Our study here has shown that miR-17, a member of the miR-
17–92 cluster, is an important regulator of p21 expression and
www.frontiersin.org July 2014 | Volume 5 | Article 132 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chen et al. miR-17 targets p21 during neurogenesis
FIGURE 6 | miR-17 rescues the negative effect of p21 on proliferation of
neural progenitors. (A,B) Co-expression of miR-17 with p21 in E13.5 mouse
cortices (n=6), analyzed at E14.5, significantly rescued the reduced number
of proliferating cells caused by p21 alone, while co-expression of a mutated
miR-17 with p21 (n=3) failed to do so. (C,D) Co-expression of miR-17 with
p21 (n=5) significantly rescued the reduced number of RGCs caused by p21
alone, while co-expression of a mutated miR-17 (miR-17-mut) with p21 (n=3)
failed to do so. (E,F) Co-expression of miR-17 with p21 (n=5) significantly
rescued the reduced number of IPs caused by p21 alone, while co-expression
of a mutated miR-17 with p21 (n=3) failed to do so. Data are presented as
mean±SEM; n≥3 in all constructs; p values in relation to the control
(**p< 0.01, ***p<0.001), n.s., not significant.
expansion of the cortical neural progenitor pool. miR-17 dis-
plays decreased expression in mouse cortices at embryonic and
postnatal stages, which is opposite to that of p21, suggesting a
reciprocal expression between miR-17 and its target p21. These
results further suggest that higher expression of miR-17 in embry-
onic cortices is crucial for suppressing the p21 level and promoting
NP proliferation, while low expression of miR-17 in postnatal
cortices allows p21 expression to induce differentiation. Further-
more, we have found the direct silencing action of miR-17 on
p21 in vivo, since co-expression of p21 and miR-17, but not miR-
17 mutations, can block negative effects of p21 on cortical NP
proliferation.
It is likely that silencing p21 by miR-17 in proliferative cells is
a general rule. The targeting effects of miR-17 and p21 have been
observed in oral carcinoma cells, acute myeloid leukemia cells, and
Hodgkin’s lymphoma (39–41). Furthermore, miR-17 likely main-
tains the neural progenitor pool by regulating several targets. In
this study, we have demonstrated miR-17 targeting effect on p21
expression. Here, we have not ruled out the likely possibility that
the regulation of additional target genes by miR-17 contributes to
its ability to promote NP proliferation. For instance, miR-17 has
been shown to enhance NSC self-renewal by targeting Trp53inp1, a
gene in the p53 pathway, to promote NP proliferation by silencing
bone morphogenetic protein type II receptor (42, 43).
Therefore, proper self-renewal of NSCs and expansion of NPs
in the developing cortex relies on balanced expression levels of cell
cycle regulators such as p21. One of the mechanisms that control
precise expression levels of these regulators is through the miRNA
silencing regulation such as miR-17.
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